{"date":"2025-03-24","count":38,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6797-2025-03-24-2024-1l84nyy","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"20:24:49","subject":"公告本公司董事會決議113年度股利分派情形","clause":"第31款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-03-24 20:24，「公告本公司董事會決議113年度股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-03-24-2012-120388b","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"20:12:12","subject":"公告本公司董事會議決議召開股東常會相關事宜","clause":"第32款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-03-24 20:12，「公告本公司董事會議決議召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-03-24-2010-rfrtx0","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"20:10:32","subject":"公告本公司董事會決議不分派113年度員工酬勞及董事酬勞","clause":"第44款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-03-24 20:10，「公告本公司董事會決議不分派113年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-03-24-2009-15802ya","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"20:09:43","subject":"公告本公司董事會通過113年度財務報表","clause":"第43款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-03-24 20:09，「公告本公司董事會通過113年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-03-24-1938-1hku5w3","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"19:38:21","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-03-24 19:38，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-03-24-1936-drgvb6","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"19:36:56","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-03-24 19:36，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-03-24-1925-bwopfv","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"19:25:49","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-03-24 19:25，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-03-24-1924-1pb8ufa","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"19:24:59","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-03-24 19:24，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1826-4xw05f","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:26:03","subject":"本公司董事會決議虧損撥補案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:26，「本公司董事會決議虧損撥補案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1825-1owu0fj","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:25:06","subject":"本公司因會計師事務所內部調整變更簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:25，「本公司因會計師事務所內部調整變更簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1816-5rax5d","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:16:46","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:16，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1816-drgvb6","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:16:24","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:16，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1815-1pb8ufa","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:15:57","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:15，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-03-24-1815-1lnd450","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:15:35","subject":"公告本公司董事會通過民國113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-24 18:15，「公告本公司董事會通過民國113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-24-1809-1ipjggb","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"18:09:52","subject":"本公司異體間質幹細胞新藥Chondrochymal治療退化性關節炎三期臨床試驗計畫，接獲衛生福利部通知臨床試驗執行醫院GTP訪查結果核可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-24 18:09，「本公司異體間質幹細胞新藥Chondrochymal治療退化性關節炎三期臨床試驗計畫，接獲衛生福利部通知臨床試驗執行醫院G」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-03-24-1808-1oc7ahp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-03-24","time":"18:08:44","subject":"(代子公司公告)TDW HK Limited董事會決議增資北瑞藥業(福建)有限公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-03-24 18:08，「(代子公司公告)TDW HK Limited董事會決議增資北瑞藥業(福建)有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-03-24-1742-1m7d12f","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"17:42:21","subject":"本公司董事會決議114年股東常會召開事宜","clause":"第32款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-03-24 17:42，「本公司董事會決議114年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-03-24-1737-gi3647","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"17:37:43","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-03-24 17:37，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-03-24-1732-1utl0ou","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"17:32:48","subject":"本公司董事會決議發行限制員工權利新股","clause":"第9款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-03-24 17:32，「本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-03-24-1731-1jrex0f","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"17:31:54","subject":"公告本公司執行長、策略長、財務及會計主管、公司治理主管、發言人及代理發言人異動","clause":"第8款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-03-24 17:31，「公告本公司執行長、策略長、財務及會計主管、公司治理主管、發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-03-24-1731-1g6i233","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"17:31:29","subject":"公告本公司董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-03-24 17:31，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-03-24-1724-2iz4hx","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"17:24:09","subject":"公告本公司董事會決議不發放股利","clause":"第31款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-03-24 17:24，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-03-24-1712-1cdccif","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"17:12:10","subject":"本公司檢測試劑DNlite uPTM-FetA ELISA Kit獲得馬來西亞主管機關核發上巿許可，適用範圍延伸到用於評估腎移植(KT)患者腎功能失效預後的風險檢測。","clause":"第44款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-03-24 17:12，「本公司檢測試劑DNlite uPTM-FetA ELISA Kit獲得馬來西亞主管機關核發上巿許可，適用範圍延伸到用於評」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-24-1708-1uii2xt","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"17:08:15","subject":"本公司董事會通過召開114年股東常會相關事宜(更正)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-24 17:08，「本公司董事會通過召開114年股東常會相關事宜(更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-03-24-1653-1pe5i2t","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"16:53:43","subject":"公告本公司董事會決議通過113年度合併財務報告","clause":"第43款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-03-24 16:53，「公告本公司董事會決議通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-03-24-1651-7agge","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"16:51:44","subject":"代重要子公司創益生技股份有限公司公告重要營運主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-03-24 16:51，「代重要子公司創益生技股份有限公司公告重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-03-24-1634-19w90xp","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"16:34:27","subject":"更正本公司私募專區(董事會決議日起兩日內應申報相關資訊)","clause":"第53款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-03-24 16:34，「更正本公司私募專區(董事會決議日起兩日內應申報相關資訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-03-24-1632-7f3nd4","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-03-24","time":"16:32:15","subject":"本公司受邀參加富邦證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-03-27","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-03-24 16:32，「本公司受邀參加富邦證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-03-24-1553-4yns53","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"15:53:24","subject":"本公司董事會決議113年度股利分派","clause":"第31款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-03-24 15:53，「本公司董事會決議113年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-24-1545-1is8h0m","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"15:45:55","subject":"公告本公司董事長訂定民國113年第四季盈餘之除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-24 15:45，「公告本公司董事長訂定民國113年第四季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-03-24-1542-yk0q3d","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"15:42:52","subject":"公告本公司113年度累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-03-24 15:42，「公告本公司113年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-03-24-1542-mxr1to","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"15:42:10","subject":"本公司董事會通過113年度財務報表","clause":"第43款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-03-24 15:42，「本公司董事會通過113年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-24-1541-91etty","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"15:41:12","subject":"(補)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-24 15:41，「(補)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-03-24-1540-cievxs","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-03-24","time":"15:40:53","subject":"本公司董事會決議召開114年股東常會","clause":"第32款","fact_date":"2025-03-24","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-03-24 15:40，「本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-24-1539-1jjtc9d","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"15:39:15","subject":"(更正)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-24 15:39，「(更正)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-24-1538-1uodtv3","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"15:38:55","subject":"(補)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-24 15:38，「(補)依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-03-24-1521-1nfd8ol","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-03-24","time":"15:21:47","subject":"因近期股價異常，櫃買中心通知達公布注意交易資訊標準，公布本公司相關財務業務資訊。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-03-24 15:21，「因近期股價異常，櫃買中心通知達公布注意交易資訊標準，公布本公司相關財務業務資訊。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-03-24-1521-crlpwq","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-03-24","time":"15:21:41","subject":"代子公司嘉文麗（福建）化妝品有限公司公告累積取得或處分理財產品","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-03-24 15:21，「代子公司嘉文麗（福建）化妝品有限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}